Introduction HIV incidence remains high among African adolescent girls and young women
(AGYW). The primary objective of this study is to assess pre‐exposure prophylaxis (PrEP) …

Background In sub-Saharan Africa (SSA), adolescent girls and young women (AGYW) ages
15 to 24 years represent< 10% of the population yet account for 1 in 5 new HIV infections …

Background Pre-exposure prophylaxis (PrEP) is highly effective and an important prevention
tool for African adolescent girls and young women (AGYW), but adherence and persistence …

Background Adolescent girls and young women in southern and eastern Africa have
adherence challenges with daily oral HIV pre-exposure prophylaxis (PrEP). High adherence …

Introduction HIV incidence remains high among African adolescent girls and young women
(AGYW), who would benefit from pre‐exposure prophylaxis (PrEP). Strategies to increase …

Few studies have sought to understand factors influencing uptake and continuation of pre-
exposure prophylaxis (PrEP) among young adults in sub-Saharan Africa in the context of …

Introduction Adolescent girls and young women (AGYW) in Africa have high HIV incidence
despite scale‐up of HIV testing and HIV treatment. Placebo‐controlled trials of tenofovir …

Introduction Of the two million new HIV infections in adults in 2014, 70% occurred in sub‐
Saharan Africa. Several African countries have already approved guidelines for pre …

Objective: To present detailed analyses of long-term pre-exposure prophylaxis (PrEP) use
and associated behaviors and perceptions among young Kenyan women. Design …

Successful scale-up of PrEP for HIV prevention in African adolescent girls and young
women (AGYW) requires integration of PrEP into young women's everyday lives. We …